2.4.1. Baseline visit 1

At Baseline Visit 1, eligible individuals will complete the written informed consent with assistance from the trained research staff. Those who are consented and complete the baseline survey questionnaires will commence a 7-day usual physical activity and glucose monitoring period. During this period, all participants will wear an activPAL3 device (PAL Technologies) on the thigh and a continuous glucose monitor (CGM, Abbott FreeStyle Libre Pro) on the upper arm and follow their usual diet and activity. Participants will receive $25 for the completion of the Baseline Visit 1.